The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus

PURPOSE: The aim of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of a single 12.5- or 25-mg dose of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, in pediatric (children and adolescents) and adult subjects with type 2 diabetes mellitus (T2DM). METHODS: A ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudkowski, Caroline, Tsai, Max, Liu, Jie, Zhao, Zhen, Schmidt, Eric, Xie, Jeannie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306220/
https://www.ncbi.nlm.nih.gov/pubmed/27999883
http://dx.doi.org/10.1007/s00228-016-2175-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306220/
https://www.ncbi.nlm.nih.gov/pubmed/27999883
http://dx.doi.org/10.1007/s00228-016-2175-1

Ejemplares similares